Tratamiento de la insuficiencia cardiaca avanzada en el siglo XXI. El trasplante cardiaco en la encrucijada

Juan F. Delgado Jiménez
{"title":"Tratamiento de la insuficiencia cardiaca avanzada en el siglo XXI. El trasplante cardiaco en la encrucijada","authors":"Juan F. Delgado Jiménez","doi":"10.1016/S1131-3587(15)30002-9","DOIUrl":null,"url":null,"abstract":"<div><p>Today heart transplantation is an accepted and established treatment for advanced heart failure. However, since the first procedure in Spain was performed in 1984, there have been substantial, unfavorable changes in donor and recipient profiles, as well as in the circumstances under which patients present for transplantation. These changes have taken place in parallel with medical and surgical advances in heart transplantation, such that, overall, outcomes have not been greatly affected. Nevertheless, it is important that the number of transplantations is either maintained or increased, that the good results obtained so far are sustained, that organs continue to be allocated as fairly as possible and that mortality among patients on the waiting list is reduced. This article considers the changes that have occurred in the field and reviews proposals for future improvements.</p></div>","PeriodicalId":34926,"journal":{"name":"Revista Espanola de Cardiologia Suplementos","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1131-3587(15)30002-9","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola de Cardiologia Suplementos","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1131358715300029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Today heart transplantation is an accepted and established treatment for advanced heart failure. However, since the first procedure in Spain was performed in 1984, there have been substantial, unfavorable changes in donor and recipient profiles, as well as in the circumstances under which patients present for transplantation. These changes have taken place in parallel with medical and surgical advances in heart transplantation, such that, overall, outcomes have not been greatly affected. Nevertheless, it is important that the number of transplantations is either maintained or increased, that the good results obtained so far are sustained, that organs continue to be allocated as fairly as possible and that mortality among patients on the waiting list is reduced. This article considers the changes that have occurred in the field and reviews proposals for future improvements.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
21世纪晚期心力衰竭的治疗。心脏移植处于十字路口
今天,心脏移植是晚期心力衰竭的一种公认的治疗方法。然而,自从1984年在西班牙进行第一次手术以来,供体和受体的情况以及患者接受移植的情况都发生了重大的不利变化。这些变化与心脏移植的医学和外科技术的进步同时发生,因此,总体而言,结果没有受到很大影响。然而,重要的是维持或增加移植数量,维持迄今取得的良好结果,继续尽可能公平地分配器官,减少等候名单上的病人死亡率。本文考虑了该领域已经发生的变化,并回顾了未来改进的建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Revista Espanola de Cardiologia Suplementos
Revista Espanola de Cardiologia Suplementos Medicine-Cardiology and Cardiovascular Medicine
CiteScore
1.20
自引率
0.00%
发文量
1
期刊介绍: Revista Española de Cardiología, is an international scientific journal dealing with cardiovascular medicine. Revista Española de Cardiología, the official publication of the Spanish Society of Cardiology, publishes research articles related to cardiovascular diseases. Articles are published in Spanish for the paper edition and in both Spanish and English in the electronic edition, which is available on the Internet. Regular sections include original articles reporting clinical or basic research, brief reports, review articles, editorials and letters to the Editor.
期刊最新文献
Riesgo residual. Conclusiones Consideraciones clínicas y estrategias terapéuticas para reducir el riesgo residual Icosapento de etilo en la disminución del riesgo residual. Nuevas evidencias Recomendaciones actuales de las guías respecto al riesgo residual ¿Qué es el riesgo cardiovascular residual? Etiología, lípidos e inflamación
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1